Neurocrine Biosciences, Inc.

0K6R.L·LSE
Compare
168.10−0.40 (−0.24%)today
At close: Nov 4, 7:14 PM GMT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close168.50
Open168.98
Day range161.83169.04
52-week range118.72190.00
Off day high−0.56%
Off 52-week high−11.53%
Volume510
Avg. volume (3M)1.01K
Market cap—
EPS (TTM)0.7300
Forward P/E—
P/E ratio (TTM)230.27
Dividend yield—
Beta (5Y)0.40
Shares outstanding90.68M
Short interest—
Earnings dateNov 2, 2026
Analyst target—
Profit margin20.91%

Against its peers

Compare in full ›
0K6R.L NMRA NEU.AX ACAD ATAI PRAX
Market cap — 106.35M 2.95B 3.70B — 7.95B
P/E (TTM) 230.3 — 154.9 9.6 — —
Forward P/E — -0.9 38.9 23.3 — -30.0
Price/book 4.4 2.4 8.8 3.0 — 5.9
Dividend yield — — 1.52% — — —
1-year change +8.43% −78.06% −2.22% −0.83% — +65.24%
Today −0.24% −0.86% +17.49% +4.38% 0.00% +1.53%

The closest companies by business. Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to Neurocrine Biosciences's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Neumora Therapeutics, Inc.NMRA · Biotechnology 106.35M 0.5660 −0.86%
Neuren Pharmaceuticals LimitedNEU.AX · Biotechnology 2.95B 23.24 +17.49%
Acadia Pharmaceuticals Inc.ACAD · Biotechnology 3.70B 21.47 +4.38%
AtaiBeckley Inc.ATAI · Biotechnology 2.73B 7.35 0.00%
Praxis Precision Medicines, Inc.PRAX · BiotechnologyOdds 7.95B 284.79 +1.53%
Saniona AB (publ)SANION.ST · Biotechnology 1.53B 11.08 +3.17%
BioArctic AB (publ)B9A.F · Biotechnology 2.45B 27.58 −0.29%
Biogen Inc.BIIB · Drug Manufacturers - General 37.61B 254.46 +2.22%

Also based in San Diego, California, then elsewhere in California.

Company Mkt cap Price Today
QUALCOMM IncorporatedQCOM · San Diego, CA 184.94B 173.19 +5.33%
Illumina, Inc.ILMN · San Diego, CA 34.25B 226.54 −4.90%
Realty Income CorporationO · San Diego, CA 56.04B 59.22 +2.99%
DexCom, Inc.DXCM · San Diego, CA 33.00B 88.48 +6.64%
SempraSRE · San Diego, CA 54.21B 82.90 −2.88%
ResMed Inc.RMD · San Diego, CA 33.83B 240.51 +5.91%
LPL Financial Holdings Inc.LPLA · San Diego, CAOdds 24.25B 311.48 +4.64%
Halozyme Therapeutics, Inc.HALO · San Diego, CA 14.79B 130.34 +1.34%

What visitors to Neurocrine Biosciences's page also look at.

Company Mkt cap Price Today
HALOZYME THERAPEUTICS INC HALOZ0J2O.L — 130.20 −0.06%
MARKEL CORP MARKEL ORD SHS0JYM.L — 1,941.76 +1.56%
AXON ENTERPRISE INC AXON ENTERP0HKE.L — 425.64 +2.04%
LULULEMON ATHLETICA INC LULULEM0JVT.L — 112.60 +0.16%
ARAMARK ARAMARK ORD SHS0HHB.L — 54.80 +0.83%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All 0K6R.L news ›
Neurocrine Biosciences··2 outletsPositive

Neurocrine Biosciences Reports Third-Quarter 2026 Financial Results

Total Third-Quarter 2026 Revenue Grew 41% Year-Over-Year to $1.1 Billion INGREZZA® (valbenazine) 2026 Net Sales Guidance Raised to $2.9 to $2.925 Billion SAN DIEGO, Nov. 2, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX)…

NBIXCNSPASPE
More from 1 other outlet

From the 4Search news index, newest first.

In the news

27mentions in 30 days
27with it in the headline
Positivesentiment

Mentioned with

Neurocrine Biosciences, Inc.19Biogen9Eli Lilly9Neurocrine9Neurocrine Biosciences, Inc7Intellia Therapeutics6Novo Nordisk6TD Cowen6

People in the coverage

Mitch Edgeman23Danessa Lincoln15Kim Johansen12Neurogene12David W. Boyer11Huntington9

Themes

Healthcare21Nbix18Earnings14SEC Filings10Stock Analysis10Comparison8Review8Stock Comparison8

Most coverage from

  1. seekingalpha.com6
  2. marketscreener.com5
  3. stocktitan.net3
  4. defenseworld.net2
  5. pluang.com2

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 27 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance